Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-45.03%
operating margin TTM
-36.67%
revenue TTM
979.54 Million
revenue per share TTM
12.42$
valuation ratios | |
|---|---|
| pe ratio | -9.17 |
| peg ratio | -0.45 |
| price to book ratio | -3.03 |
| price to sales ratio | 4.24 |
| enterprise value multiple | -13.82 |
| price fair value | -3.03 |
profitability ratios | |
|---|---|
| gross profit margin | 86.14% |
| operating profit margin | -36.67% |
| pretax profit margin | -45.01% |
| net profit margin | -45.03% |
| return on assets | -21.31% |
| return on equity | 36.09% |
| return on capital employed | -26.32% |
liquidity ratio | |
|---|---|
| current ratio | 2.35 |
| quick ratio | 2.31 |
| cash ratio | 1.34 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 75.73 |
| operating cycle | 147.46 |
| days of payables outstanding | 56.40 |
| cash conversion cycle | 91.06 |
| receivables turnover | 5.09 |
| payables turnover | 6.47 |
| inventory turnover | 4.82 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.45 |
| debt equity ratio | -2.25 |
| long term debt to capitalization | 2.09 |
| total debt to capitalization | 1.80 |
| interest coverage | -1.77 |
| cash flow to debt ratio | -0.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.52 |
| cash per share | 14.83 |
| operating cash flow per share | -1.40 |
| free cash flow operating cash flow ratio | 1.09 |
| cash flow coverage ratios | -0.04 |
| short term coverage ratios | -0.42 |
| capital expenditure coverage ratio | -11.66 |
Frequently Asked Questions
When was the last time PTC Therapeutics, Inc. (NASDAQ:PTCT) reported earnings?
PTC Therapeutics, Inc. (PTCT) published its most recent earnings results on 07-11-2024.
What is PTC Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. PTC Therapeutics, Inc. (NASDAQ:PTCT)'s trailing twelve months ROE is 36.09%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. PTC Therapeutics, Inc. (PTCT) currently has a ROA of -21.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PTCT's net profit margin stand at?
PTCT reported a profit margin of -45.03% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PTCT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.35 in the most recent quarter. The quick ratio stood at 2.31, with a Debt/Eq ratio of -2.25.